This course is being codirected by the Johns Hopkins Brain Science Institute.
Applications must be received no later than Tuesday, October 15, 2013
About The Program
This training program in neurotherapeutics discovery and development is an intensive 3 -day course that will provide trainees with the various knowledge elements required to discover and advance a neurotherapeutic agent to Investigational New Drug (IND) Application. Following the course, the training program will continue for a two-year period during which students will have individualized mentoring. The training, which is designed to be applicable to diverse diseases of the nervous system, will equip students with a broad understanding of the various component steps in the neurotherapeutics drug discovery and development process.
Students will learn:
In sum, students will be equipped with the skills to develop and coordinate a drug discovery and development effort and work collaboratively with subject experts in each of the component areas.
Michael A. Rogawski, MD, PhD, University of California, Davis
Barbara Slusher, PhD, Johns Hopkins Brain Science Institute
Marci Glicksman, PhD, Brigham and Women’s Hospital and Harvard Medical School
Karl Scheidt, PhD, Northwestern University
To learn more about the objectives and the application process go to http://www.neurotherapeuticscourse.org